Development of a drug-eluting microstent for micro-invasive glaucoma surgery
Glaucoma represents the leading cause of irreversible blindness worldwide. Therapeutic approaches are based on the lowering of intraocular pressure (IOP). Micro-invasive glaucoma surgery (MIGS) offers perspectives for implant based IOP-reduction with reduced complication rates compared to convention...
Main Authors: | Siewert Stefan, Pfensig Sylvia, Großmann Swen, Stiehm Michael, Schmitz Klaus-Peter, Schmidt Wolfram, Kohse Stefanie, Wulf Katharina, Grabow Niels, Kopp Franziska, Guthoff Rudolf |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2018-09-01
|
Series: | Current Directions in Biomedical Engineering |
Subjects: | |
Online Access: | https://doi.org/10.1515/cdbme-2018-0145 |
Similar Items
-
Development of a microstent system for minimally invasive glaucoma surgery
by: Siewert Stefan, et al.
Published: (2017-09-01) -
Development of a limbal fixation mechanism for a minimally invasive implantable glaucoma microstent
by: Siewert Stefan, et al.
Published: (2020-09-01) -
Development of an antifibrotic drug-eluting coating for a minimally invasive implantable glaucoma microstent
by: Siewert Stefan, et al.
Published: (2019-09-01) -
Extrusion as a manufacturing process for polymer micro-tubes for various bio-medical applications
by: Sahmel Olga, et al.
Published: (2019-09-01) -
Miniaturization in Glaucoma Monitoring and Treatment: A Review of New Technologies That Require a Minimal Surgical Approach
by: H. Burkhard Dick, et al.
Published: (2019-02-01)